From white papers and blogs to feature stories and reports, our global health library features a variety of resources and publications to help improve quality assurance across the medicine supply chain.
Featured publications
Report: 2023 global health impact
In 2023, we improved the availability and affordability of quality-assured medical products for millions of people worldwide.
Brochure: Expanding access to quality medical products
We strengthen the global supply chain so that the medicines, vaccines, and diagnostics that patients rely on are available when needed and work as expected.
White paper: Expanding capacity to produce vaccines in Africa
Building capacity in Africa to produce vaccines for routine immunizations and health emergencies will save lives and improve public health.
Explore other publications
Brochure
- Expanding access to quality medical products – August 2023 (PDF)
Blogs
- Drivers of global health impact in 2024 – December 2023
- Beyond TB medicines: How quality assurance is elevating health systems in Central Asia – October 2023
- Africa’s growing vaccine capacity – Feb 2023
- Tackling medicine supply shortages starting with their ingredients – Oct 2022
- Fighting maternal mortality: How standards keep new moms safe – May 2022
- Bolstering capabilities to support the supply of quality medicines – March 2022
- Four global health resolutions for 2022 – Jan 2022
- Archived blogs
Feature stories
- Ensuring quality medicines for patients in Southeast Asia – August 2023
- Tackling drug resistant TB - March 2023
- Building a resilient medicine supply chain to combat tuberculosis – March 2022
Press releases
- Donated laboratory equipment to help Ghana protect patients from poor-quality medicines – July 2023
- USP and Africa CDC launch MOU to advance regional manufacturing and strengthen regulatory and laboratory systems in Africa - June 2023
- Nigeria pharmaceutical company first to receive WHO prequalification in West Africa - June 2023
- U.S. Pharmacopeia expands efforts to promote medicine quality in Asia Pacific – Sept 2022
- USAID provides $7.1 million to USP to build trust in the supply of vaccines through the Promoting the Quality of Medicines Plus (PQM+) Program – Aug 2022
- SAHPRA and USP Announce MOU to Advance Regulatory Oversight for Medical Products in South Africa – Jan 2022
- USP and DFAT Partner to Strengthen Laboratories and Improve Medicines Quality in Cambodia and Laos – Sept 2020
- New Collaboration Aims to Reduce Infant Mortality in Developing Countries by Making Life-Saving Antiseptic More Widely Available – Sept 2018
- Ronald T. Piervincenzi Statement of Support for WHO Reports on Impact of Poor-Quality Medicines – 2017
Technology reviews
- Paper Analytical Device – Oct 2020 (PDF)
- Target-ID review – May 2020 (PDF)
- Speedy Breedy review – 2017 (PDF)
- CBEx Handheld Raman Spectrometer – 2017 (PDF)
- ASD QualitySpec® (Trek) – May 2019 (PDF)
- Global Pharma Health Fund( GPHF)-Minilab™ – Aug 2020 (PDF)
White papers and reports
- 2023 Global Health Impact Report - Nov 2023
- Expanding capacity to produce vaccines in Africa: Enablers and barriers – Feb 2023
- Resources for risk-based post-marketing surveillance (EN, ES) – Oct 2021 (PDF)
- Last-mile manufacturing of vaccines: Recommendations for scaling-up production of COVID-19 vaccines in Africa – April 2021
- Confronting substandard and falsified COVID-19 vaccines: Strategies and tools for use in global settings – Aug 2021
- Pandemic Preparedness for Regulators in Low- and Middle-Income Countries (EN, ES) – 2021 (PDF)
- Accelerating the rollout of COVID-19 vaccines: A how-to guide for national regulatory authorities in low- and middle-income countries – Dec 2020
- The next frontier for the public health medicines market – Aug 2019 (PDF)
Other resources